Skip to content
ppharmaranks
Menu
Class IITerminated

Lisinopril Tablets recall

FDA recall D-0061-2025 · initiated Nov 15, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Nov 27, 2024How we research

Evaric Pharmaceuticals Inc. recalled Lisinopril Tablets in Nov 2024 — an FDA Class II recall (D-0061-2025) because Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 241103, exp. date 05/31/2026

Quantity recalled: 222, 600 bottles

Details

Product
Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90.
Recalling company
Evaric Pharmaceuticals Inc.
Classification
Class II
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Nov 15, 2024
FDA report date
Nov 27, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Lisinopril Tablets recalled?
Evaric Pharmaceuticals Inc. recalled Lisinopril Tablets in Nov 2024 — an FDA Class II recall (D-0061-2025) because Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Lisinopril Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0061-2025 was: Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet.
Is a recalled Lisinopril Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Lisinopril Tablets are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot #: 241103, exp. date 05/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0061-2025.

Source: openFDA Drug Enforcement record D-0061-2025

← All drug recalls